Savara (SVRA) Other Non Operating Income (2010 - 2026)
Savara's (SVRA) quarterly Other Non Operating Income came in at -$216000.0 in Q1 2026, down 460.0% year-on-year from $60000.0 in Q1 2025, and down 118.26% on a QoQ basis from $1.2 million in Q4 2025.
Savara (SVRA) Other Non Operating Income (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Other Non Operating Income data on file, last reported at -$216000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 460.0% year-over-year to -$216000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 79.69% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 35.61% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$216000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Other Non Operating Income for SVRA reached as high as $7.5 million in Q4 2024 and fell as low as -$254000.0 in Q1 2022.
- Historically, Other Non Operating Income has averaged $916941.2 across 5 years, with a median of $60000.0 in 2025.
- Across the five-year window, Other Non Operating Income jumped 210800.0% in 2024 and slumped 460.0% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$40000.0 in 2022, then soared by 3927.5% to $1.5 million in 2023, then jumped by 388.63% to $7.5 million in 2024, then slumped by 84.19% to $1.2 million in 2025, then slumped by 118.26% to -$216000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$216000.0 in Q1 2026, $1.2 million in Q4 2025, and $146000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -216,000.00 |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 947,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | -40,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | -254,000.00 |
| Dec 31, 2021 | 767,000.00 |
| Sep 30, 2021 | -574,000.00 |
| Jun 30, 2021 | 43,000.00 |